1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Nonmalignant Neoplasm: new trials by email Literature Review of Nonmalignant Neoplasm trials Research Report on Nonmalignant Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure alemtuzumab, cyclosporine - Nonmalignant Neoplasm | Phase 2 | Unknown | Federico II University | 50 | 2006-06-01 | 2013-08-12 |
Anemia, Aplastic (1) · Neoplasms (1)
Anemia (1) · Bone Marrow Diseases (1) · Bone Marrow Failure Disorders (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Alemtuzumab (1) · Cyclosporine (1)
Italy (1)
Bruno Rotoli, MD (1)